Karyopharm Therapeutics Inc. (KPTI) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Karyopharm Therapeutics I...

    NASDAQ: KPTI · Real-Time Price · USD
    6.38
    0.09 (1.43%)
    At close: Oct 03, 2025, 3:59 PM
    6.69
    4.86%
    After-hours: Oct 03, 2025, 07:52 PM EDT

    Karyopharm Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -1.08 -0.69 -1.68 -3.89
    PEG Ratio
    		 0.02 0.02 -0.08 0.10
    PS Ratio
    		 0.57 0.68 1.77 2.30
    PB Ratio
    		 -0.44 -0.73 -16.71 -6.06
    P/FCF Ratio
    		 -0.65 -1.07 -1.86 -4.28
    P/OCF Ratio
    		 -0.65 -1.07 -1.86 -4.51
    OCF/S Ratio
    		 -0.88 -0.63 -0.95 -0.51
    Debt / Equity Ratio
    		 -1.05 -1.3 -10.75 -2.27
    Quick Ratio
    		 1.64 3.32 5.25 3.68
    Current Ratio
    		 1.70 3.37 5.31 3.74
    Asset Turnover
    		 0.88 0.61 0.44 0.69
    Interest Coverage
    		 -3.19 -5.44 -5.69 -3.77
    Return on Equity
    		 0.41 1.05 9.92 1.56
    Return on Assets
    		 -0.46 -0.6 -0.46 -0.41
    Return on Invested Capital
    		 -1.23 -0.73 -0.48 -0.42
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.96 0.97 0.97 0.98
    Net Profit Margin
    		 -0.53 -0.98 -1.05 -0.59
    Pretax Profit Margin
    		 -0.53 -0.98 -1.05 -0.59
    Operating Profit Margin
    		 -0.82 -0.89 -0.91 -0.47
    FCF Margin
    		 -0.88 -0.63 -0.95 -0.54
    EBITDA Margin
    		 -0.27 -0.81 -0.89 -0.46

    Add to Watchlist